Concepedia
Statistics
Publications
24
Citations
1.5K
H-Index
21
Active since
2008
Affiliations
National University of Singapore(Current)
National University Cancer Institute, Singapore
National University Health System
National University Hospital
Agency for Science, Technology and Research
Chonglei Bi is an author at National University of Singapore specializing in oncology, molecular oncology, and medicine.
Publications per year
2008–2021
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
Jianbiao Zhou, Chonglei Bi, Lip-Lee Cheong et al. · Blood · 2011 · 212 citations · Full text
Medicine, Cancer Biology, Molecular Biology +15
EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
Junli Yan, Siok‐Bian Ng, Jim Liang-Seah Tay et al. · Blood · 2013 · 165 citations
Medicine, Cancer Biology, Oncology +16
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara et al. · Blood · 2009 · 162 citations · Full text
Medicine, Cancer Biology, Oncology +9
EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma
Junli Yan, Boheng Li, Baohong Lin et al. · Blood · 2016 · 140 citations · Full text
Life Sciences, Cancer Biology, Cell Biology +13
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma
Siok‐Bian Ng, Junli Yan, Gaofeng Huang et al. · Blood · 2011 · 116 citations
Life Sciences, Cancer Biology, Oncology +14
1–5 of 24